Assay for the detection and quantification of HBV cccDNA by real-time PCR

• US 20040058314A1
• Filed: 05/29/2003
• Published: 03/25/2004
• Est. Priority Date: 05/29/2002
• Status: Abandoned Application

• Current Assignee: University of Hong Kong (Government of Hong Kong Special Administrative Region)
• Original Assignee: University of Hong Kong (Government of Hong Kong Special Administrative Region)
• Inventors: Lin, Marie Chia Mi, He, Ming Liang, Kung, Hsiang-Fu
• Application Number:
  US10/449,801
• Publication Number:
  US 20040058314A1
• Time in Patent Office: Days
• US Class Current: 435/5
• CPC Class Codes: C12Q 1/706 for hepatitis

Abstract

The persistence of covalently closed circular (ccc) DNA of Hepatitis B Virus (HBV) in liver cells is believed to be the major reason for relapse after completion of HBV antiviral therapy. Up to now, there is no sensitive method to quantify cccDNA in infected liver cells. A set of primers were designed to specifically amplify DNA fragments from HBV cccDNA but not from viral genomic DNA. A good linear range was obtained when 100 to 10⁷ copies of HBV cccDNA were used as template in the quantitative real-time PCR. Not only is this method rapid, economical, highly sensitive, it can be used to monitor HBV cccDNA in infected human liver biopsies and to guide patients undergoing long-term anti-HBV therapy.

Claims

1. A method for detecting covalently closed circular cccDNA of a Hepatitis B virus HBV in the form of a HBV cccDNA genome, the method comprising the steps of:

a) obtaining a sample of liver cells infected with HBV cccDNA virus from a patient;

b) preparing at least one primer for applying to at least one end of the HBV cccDNA virus;

c) amplifying said HBV cccDNA virus by a polymerase chain reaction (PCR) using said at least one primer;

d) preparing at least one probe for applying to said HBV cccDNA gnome, wherein said probe comprises a dye and a dye quencher; and

e) conducting a second polymerase chain reaction to bind said at least one primer to said at least one probe so that said dye and said dye quencher in said probe are separated allowing said HBV cccDNA to be detected via said dye.

2. The process as in claim 1, wherein said step of preparing said at least one primer comprises preparing at least one forward primer.

3. The process as in claim 1, wherein said step of preparing said at least one primer comprises preparing at least one reverse primer.

4. The process as in claim 1, wherein said step of preparing at least one primer comprises preparing at least one primer pair including at least one forward primer and at least one reverse primer.

5. The process as in claim 4, wherein said step of preparing at least one primer includes using between 100 and 10⁶ copies of plasmid HBV cccDNA as a template.

6. The process as in claim 4, wherein said step of preparing at least one primer includes using between 100 and 10⁷ copies of plasmid HBV cccDNA as a template.

7. The process as in claim 1 wherein said step of preparing at least one primer comprises preparing at least one primer pair including at least three different forward primers and at least three different reverse primers.

8. The process as in claim 1, wherein said step of preparing at least one primer includes preparing a primer consisting of:

(5′

-(SEQ ID NO;

     1)-3′

)

9. The process as in claim 1, wherein said step of preparing at least one primer includes preparing a primer consisting of:

(5′

-(SEQ ID NO;

     2)-3′

).

10. The process as in claim 1, wherein said step of preparing at least one primer includes preparing a primer consisting of:

(5′

-(SEQ ID NO;

3 -3′

).

11. The process as in claim 1, wherein said step of preparing at least one primer includes preparing a primer consisting of:

(5′

-(SEQ ID NO;

     4) -3′

).

12. The process as in claim 1, wherein said step of preparing at least one primer includes preparing a primer consisting of:

(5′

-(SEQ ID NO;

     5) -3′

).

13. The process as in claim 1, wherein said step of preparing at least one primer includes preparing a primer consisting of:

(5′

-(SEQ ID NO;

     6) -3′

).

14. The process as in claim 1, further comprising the step of:

quantifying a presence of both HBV viral and HBV cccDNA wherein said primer and said probe correspond to a surface antigene (Sgene) of said HBV.

15. The process as in claim 14, wherein said step of preparing at least one primer includes preparing a primer consisting of:

(5′

-(SEQ ID NO;

     7) -3′

).

16. The process as in claim 14, wherein said step of preparing at least one primer includes preparing a primer consisting of:

5′

-(SEQ ID NO;

     8)-3′

.

17. The process-as in claim 14, wherein said step of preparing at least one probe includes preparing a probe consisting of:

(5′

-TET-(SEQ ID NO;

     9)- TAMRA-3′

).

18. The process as in claim 14, wherein said step of preparing at least one probe includes preparing a probe consisting of:

(5′

-FAM-(SEQ ID NO;

     10)-TAMRA-3′

).

19. A kit for the detection of HBV cccDNA in a patient comprising:

a) a plurality of forward amplification primers for detecting cccDNA wherein said forward primers consist of;

(5′

-(SEQ ID NO;

     1) -3′

);

(5′

-(SEQ ID NO;

     2) -3′

);

(5′

-(SEQ ID NO;

     3)-3′

); and

b) a plurality of reverse primers wherein said reverse primers consist of;

(5′

-(SEQ ID NO;

     4)-3′

);

(5′

-(SEQ ID NO;

     5)-3′

);

(5′

-(SEQ ID NO;

     6)-3′

).

20. The kit as in claim 19, further comprising at least one probe.

21. The kit as in claim 20, wherein said probe comprises:

5′

-TET-(SEQ ID NO;

     9)-TAMRA-3′

.

22. The kit as in claim 20, wherein said probe comprises:

(5′

-FAM-(SEQ ID NO;

     12) -TAMRA-3′

).